tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Positive Outlook for Agios Pharma Despite Recent Patient Deaths Unrelated to Pyrukynd Treatment
PremiumRatingsPositive Outlook for Agios Pharma Despite Recent Patient Deaths Unrelated to Pyrukynd Treatment
2M ago
Agios Pharmaceuticals reports Pyrukynd approval by Saudi Food and Drug Authority
Premium
The Fly
Agios Pharmaceuticals reports Pyrukynd approval by Saudi Food and Drug Authority
2M ago
Agios Pharma’s PYRUKYND Approved by Saudi Authority
Premium
Company Announcements
Agios Pharma’s PYRUKYND Approved by Saudi Authority
2M ago
Agios Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany AnnouncementsAgios Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
2M ago
Agios Pharma’s Promising Growth: Buy Rating Backed by Strong Drug Performance and Strategic Focus
Premium
Ratings
Agios Pharma’s Promising Growth: Buy Rating Backed by Strong Drug Performance and Strategic Focus
2M ago
Agios Pharmaceuticals Reports Q2 2025 Financial Results
Premium
Company Announcements
Agios Pharmaceuticals Reports Q2 2025 Financial Results
2M ago
Agios Pharmaceuticals price target lowered to $51 from $52 at BofA
PremiumThe FlyAgios Pharmaceuticals price target lowered to $51 from $52 at BofA
2M ago
Agios Pharma Appoints Dr. Jay Backstrom as Director
Premium
Company Announcements
Agios Pharma Appoints Dr. Jay Backstrom as Director
3M ago
Agios Pharmaceuticals appoints Jay Backstrom to board
Premium
The Fly
Agios Pharmaceuticals appoints Jay Backstrom to board
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100